Advanced Proteome Therapeutics Reports Positive Results and Advances Collaboration with Heidelberg Pharma
pharmaceutical investing Advanced Proteome Therapeutics Announces Progress on Antibody-Radioisotope Conjugate Initiative
Alvopetro Announces Q3 2026 Dividend of US$0.12 Per Share and Supplementary Information on December 31, 2025 Prospective Resources
Skyharbour Partner Company Purecore Commences Data Compilation and Target Generation at The Yurchison Uranium Property
